Entity
Description
  • Value proposition

    Transforming Evolution into Medicine’s Greatest Asset

    For 4 billion years, evolution has been the driving force of life and the greatest challenge in medicine. At Synamics, we’re taking a bold step forward. Instead of treating diseases as static issues, we’ve developed Dynaptive, a platform designed to anticipate how diseases will evolve and design therapies that stay ahead.

  • Synamics Therapeutics | AI drug discovery

    Synamics Therapeutics uses AI and predictive modeling for precision oncology and improved drug discovery. Our adaptive medicine approach helps prolong drug effectiveness and improves outcomes for patients with intractable cancers. Learn more about Synamics Therapeutics and how we leverage AI for personalized, adaptive cancer therapies.

  • https://www.synamics.com/
Catalyst interactions
Catalyst TypeTweets Articles
European Innovation Council and SMEs Executive Agency (EISMEA) European Innovation Council and SMEs Executive Agency (EISMEA)
Startup accelerator & VC
Other

1 Dec 2023


J.P. Morgan J.P. Morgan
Bank
Other

30 Nov 2024


Dia & Co
Dia & Co
Semiconductors, Retail Apparel and Fashion
Dia & Co
Semiconductors, Retail Apparel and Fashion
Other

30 Sep 2024


Collision Conf Collision Conf
Other

30 May 2024


Google
Google
IT services, Software Development
Google
IT services, Software Development
Other

17 Apr 2024


Novo Nordisk
Novo Nordisk
Pharmaceutical, Pharmaceutical Manufacturing
Novo Nordisk
Pharmaceutical, Pharmaceutical Manufacturing
Other

2 Feb 2025


Eurostat
Eurostat
European Union, Environmental Services
Eurostat
European Union, Environmental Services
Other

1 Dec 2023


Social network dynamics
Similar entities
BETA
Loading...
Loading...